Detalles de la búsqueda
1.
Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial.
Lancet Oncol
; 23(3): 406-415, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35074072
2.
Comparison of intravitreal injection of Ranibizumab versus Conbercept in the treatment of retinopathy of prematurity / 国际眼科杂志(Guoji Yanke Zazhi)
International Eye Science
; (12): 697-703, 2024.
Artículo
en Zh
| WPRIM | ID: wpr-1016580
3.
Study on the time of recovery to the respiratory baseline after receiving treatment of retinopathy of prematurity / 中华实用儿科临床杂志
Chinese Journal of Applied Clinical Pediatrics
; (24): 1745-1749, 2022.
Artículo
en Zh
| WPRIM | ID: wpr-954827
4.
Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trial.
Lancet Haematol
; 4(2): e67-e74, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28089238
5.
Effects of perinatal infection on retinopathy of prematurity / 中华实用儿科临床杂志
Chinese Journal of Applied Clinical Pediatrics
; (24): 759-762, 2017.
Artículo
en Zh
| WPRIM | ID: wpr-610513
6.
Characteristics of retinal vascularization in premature infants / 中华围产医学杂志
Chinese Journal of Perinatal Medicine
; (12): 478-481, 2014.
Artículo
en Zh
| WPRIM | ID: wpr-453806
7.
Determination of Gallic Acid and Caffeine in Tea Pigment by RP-HPLC / 中国药房
China Pharmacy
; (12)2005.
Artículo
en Zh
| WPRIM | ID: wpr-530878
8.
Effect of apoptosis in the pathogenesis of the great saphenous varicose result ing from primary deep venous insufficiency / 中国普通外科杂志
Chinese Journal of General Surgery
; (12)1993.
Artículo
en Zh
| WPRIM | ID: wpr-521958
Resultados
1 -
8
de 8
1
Próxima >
>>